BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25912876)

  • 1. MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.
    Ma N; Chen F; Shen SL; Chen W; Chen LZ; Su Q; Zhang LJ; Bi J; Zeng WT; Li W; Huang XH; Wang Q
    Biochem Biophys Res Commun; 2015 Jun; 461(4):618-23. PubMed ID: 25912876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
    Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
    PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
    Korhan P; Erdal E; Atabey N
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells.
    Zheng L; Pu J; Qi T; Qi M; Li D; Xiang X; Huang K; Tong Q
    Mol Cancer Res; 2013 Feb; 11(2):182-93. PubMed ID: 23233482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
    Sun X; Liu Y; Li M; Wang M; Wang Y
    Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
    Jiang G; Wen L; Zheng H; Jian Z; Deng W
    Cell Biochem Funct; 2016 Oct; 34(7):505-510. PubMed ID: 27748572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
    Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
    Jiang X; Shen X
    Bull Cancer; 2018 Oct; 105(10):873-883. PubMed ID: 30266288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.
    Liu D; Dong L; Liu Y; Wen D; Gao D; Sun H; Fan J; Wu W
    Tumour Biol; 2016 Apr; 37(4):5039-47. PubMed ID: 26546431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
    Wang YL; Chen CM; Wang XM; Wang L
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):51-6. PubMed ID: 26186881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
    Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
    PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.
    Dai W; Wang C; Wang F; Wang Y; Shen M; Chen K; Cheng P; Zhang Y; Yang J; Zhu R; Zhang H; Li J; Zheng Y; Lu J; Zhou Y; Xu L; Guo C
    Biochem Biophys Res Commun; 2014 Apr; 446(2):541-8. PubMed ID: 24613834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
    Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY
    Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.